Table 2.
Targets | OHC | OHCS | p value |
---|---|---|---|
HSP 90 | 1 ± 0.107 | 1.32 ± 0.121 | 0.07 |
AIF | 1 ± 0.104 | 1.10 ± 0.140 | 0.56 |
TNF alpha | 1 ± 0.099 | 0.33 ± 0.103 | 0.0004* |
p38 | 1 ± 0.216 | 0.947 ± 0.172 | 0.86 |
P-p38 | 1 ± 0.147 | 0.78 ± 0.121 | 0.26 |
ERK | 1 ± 0.060 | 1.19 ± 0.081 | 0.079 |
P-ERK | 1 ± 0.238 | 0.59 ± 0.106 | 0.14 |
P-NFK Beta | ND | ND | ND |
BCL 2 | 1 ± 0.138 | 1.80 ± 0.236 | 0.02* |
BAX | 1 ± 0.073 | 1.25 ± 0.118 | 0.10 |
BAD | 1 ± 0.084 | 1.36 ± 0.204 | 0.41 |
Caspase 3 | ND | ND | ND |
Caspase 9 | ND | ND | ND |
Caspase 12 | 1 ± 0.182 | 0.723 ± 0.123 | 0.28 |
Protein expression listed as fold change ± SEM compared to OC.
indicates significant difference between OHC and OHCS group (P value < 0.05). P values determined from a t-test. ND: Not Detected - indicates protein levels not detected with western blotting using similar assay as performed in ischemic myocardium.